Form 4 for AMGN Amgen
Accepted 2024-05-09 00:00:00 ET · period of report 2024-05-07 · accession 0001127602-24-014854 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-09 | 2024-05-07 | AMGN | Griffith Peter H. | EVP, CFO | A - Grant | $0.00 | +3,196 | 36.0K | +10% | $0 |
| D | 2024-05-09 | 2024-05-07 | AMGN | Griffith Peter H. | EVP, CFO | A - Grant | $300.30 | +20.8K | 20.8K | New | +$6.24M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-07 | A | A | 3,196 | $0.00 | 35,973 | D | — | — | (F1) The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively. (F2) These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,135 RSUs which will vest on 4/30/2025; 2,611 RSUs which will vest in installments of 1,286 on 5/2/2025, and one installment of 1,325 on 5/2/2026; 3,814 RSUs which will vest in installments of 1,258 on 5/2/2025, 1,259 on 5/2/2026 and 1,297 on 5/2/2027; and 3,196 RSUs which will vest in installments of 1,054 on 5/7/2026, 1,055 on 5/7/2027, and 1,087 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. (F3) These shares include 426 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount. |
| 2 | Derivative | Nqso (Right to Buy) | 2024-05-07 | A | A | 20,767 | $300.30 | 20,767 | D | $300.30 · 2026-05-07 to 2034-05-07 | 20,767 Common Stock | (F4) These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively. |